Nanovibronix (NASDAQ:FEED – Get Free Report) and Check-Cap (NASDAQ:MBAI – Get Free Report) are both small-cap manufacturing companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings and analyst recommendations.
Insider and Institutional Ownership
16.4% of Nanovibronix shares are owned by institutional investors. Comparatively, 1.1% of Check-Cap shares are owned by institutional investors. 1.4% of Nanovibronix shares are owned by insiders. Comparatively, 0.5% of Check-Cap shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Risk & Volatility
Nanovibronix has a beta of 2.21, meaning that its stock price is 121% more volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nanovibronix | $2.56 million | 1.04 | -$3.70 million | ($41.74) | -0.06 |
| Check-Cap | N/A | N/A | -$25.15 million | ($2.77) | -0.53 |
Nanovibronix has higher revenue and earnings than Check-Cap. Check-Cap is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Nanovibronix and Check-Cap’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nanovibronix | -275.12% | -24.78% | -19.24% |
| Check-Cap | N/A | N/A | N/A |
Analyst Recommendations
This is a summary of current ratings for Nanovibronix and Check-Cap, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nanovibronix | 1 | 0 | 0 | 0 | 1.00 |
| Check-Cap | 1 | 0 | 0 | 0 | 1.00 |
Summary
Nanovibronix beats Check-Cap on 6 of the 10 factors compared between the two stocks.
About Nanovibronix
NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.
About Check-Cap
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Receive News & Ratings for Nanovibronix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanovibronix and related companies with MarketBeat.com's FREE daily email newsletter.
